Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome

Leukemia

Volumn 22, Issue 3, 2008, Pages 551-558

  Jankowska, A M ^a   Gondek, L P ^a   Szpurka, H ^a   Nearman, Z P ^a   Tiu, R V ^a   Maciejewski, J P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; CYSTEINE; DNA; DNA DIRECTED DNA POLYMERASE BETA; DNA GLYCOSYLTRANSFERASE; MESSENGER RNA; PROTEIN OGG1; UNCLASSIFIED DRUG;

5Q- SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CHROMOSOME BREAKAGE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DNA DAMAGE; EXCISION REPAIR; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS;

EID: 40749119323     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405055     Document Type: Article

References (40)

1. Fenaux P. Chromosome and molecular abnormalities in myelodysplastic syndromes. Int J Hematol 2001; 73: 429-437.
2. Gondek LP, Tiu R, Haddad AS, O'Keefe CL, Sekeres MA, Theil KS et al Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS. Leukemia 2007; 21: 2058-2061.
3. Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T, Liu C et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007; 447: 686-690.
4. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447: 725-729.
5. Kuramoto K, Ban S, Oda K, Tanaka H, Kimura A, Suzuki G. Chromosomal instability and radiosensitivity in myelodysplastic syndrome cells. Leukemia 2002; 16: 2253-2258.
6. Karran P, Offman J, Bignami M. Human mismatch repair, drug-induced DNA damage, and secondary cancer. Biochimie 2003; 85: 1149-1160.
7. Fern L, Pallis M, Ian CG, Seedhouse C, Russell N, Byrne J. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS. Br J Haematol 2004; 126: 63-71.
8. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999; 286: 1897-1905.
9. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17: 1195-1214.
10. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21 361-370.
11. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285.
12. Farquhar MJ, Bowen DT. Oxidative stress and the myelodysplastic syndromes. Int J Hematol 2003; 77: 342-350.
13. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995; 358: 1-3.
14. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291: 1284-1289.
15. Samson L, Cairns J. A new pathway for DNA repair in Escherichia coli. Nature 1977; 267: 241-283.
16. Memisoglu A, Samson L. Base excision repair in yeast and mammals. Mutat Res 2000; 451: 39-51.
17. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-374.
18. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
19. Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem 2000; 267: 2135-2149.
20. Canitrot Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B et al Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci USA 1998; 95: 12586-12590.
21. Glassner BJ, Rasmussen LJ, Najarian MT, Posnick LM, Samson LD. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci USA 1998; 95: 9997-10002.
22. Powell CL, Swenberg JA, Rusyn I. Expression of base excision DNA repair genes as a biomarker of oxidative DNA damage. Cancer Lett 2005; 229: 1-11.
23. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: An enemy within. Trends Genet 1993; 9: 246-249.
24. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997; 272: 19633-19636.
25. Boiteux S, Radicella JP. The human OGG1 gene: Structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000; 377: 1-8.
26. Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001; 3: 597-609.
27. Matsumoto Y, Kim K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 1995; 269: 699-702.
28. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
29. List AF, Vardiman J, Issa JP, DeWitte TM. Myelodysplastic syndromes. Hematol Am Soc Hematol Educ Program 2004, 297-317.
30. Park J, Chen L, Tockman MS, Elahi A, Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 2004; 14: 103-109.
31. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16:3219-3225.
32. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 2004, 567: 1-61.
33. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-163.
34. Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: A pilot study. Leuk Res 2000; 24: 461-468.
35. Mambo E, Chatterjee A, de Souza-Pinto NC, Mayard S, Hogue BA, Hoque MO et al. Oxidized guanine lesions and hOgg1 activity, in lung cancer. Oncogene 2005; 24: 4496-4508.
36. Wei Q. Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996; 56: 4103-4107.
37. Cheng L, Eicher SA, Guo Z. Hong WK, Spitz MR, Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998; 7: 465-468.
38. Chen SK, Hsieh WA, Tsai MR, Chen CC, Hong AI, Wei YH et al. Age-associated decrease of oxidative repair enzymes human 8-oxoguanine DNA glycosylases (hOgg1), in human aging. J Radiat Res (Tokyo) 2003; 44: 31-35.
39. Kondo S, Toyokuni S, Tanaka T, Hiai H; Onodera H, Kasai H et al. Overexpression of the hOCG1 gene and high 8-hydroxy-2′-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHdG level in DNA. Clin Cancer Res 2000; 6 1394-1400.
40. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 2005; 162: 925-942.